| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.005 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.005 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.005 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.006 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.006 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.009 |